Vicapsys Life Sciences, Inc.
Vicapsys focuses on leveraging natural pathways in a localized manner to achieve therapeutic benefits without systemic negative consequences. Their core technology is a pleiotropic cytokine, CXCL12, formulated for various indications. The company is currently focused on curing Type 1 diabetes through long-term survival of transplanted islet cells. They also address the consequences of diabetes and localized fibrosis.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
Allogene Therapeutics, Inc.
Allogene Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They have a fully integrated team dedicated to research, development, and cell manufacturing. Their goal is to deliver "off-the-shelf" CAR T cell candidates faster and more reliably.
Prime Medicine, Inc.
Prime Medicine is a biotechnology company focused on developing gene therapies using Prime Editing technology. They aim to cure genetic diseases by precisely editing DNA. Developed at the Broad Institute, Prime Editing has the potential to address a wide range of diseases and overcome limitations of existing gene editing approaches.
IRONWOOD PHARMACEUTICALS INC
Ironwood Pharmaceuticals is a biotechnology company developing and commercializing therapies for gastrointestinal (GI) and rare diseases. They are advancing apraglutide for short bowel syndrome and have developed LINZESS® for IBS-C and chronic constipation. The company focuses on reducing the burden of diseases and addressing significant unmet needs.